Fetal Transplacental Therapy to Mitigate Consequences of Cystic Fibrosis Author links open overlay panelCharissa W. Kam PharmD, BCPPS, CPP 1 #, Cameron J. McKinzie PharmD, BCPPS, BCPS, CPP 1 #, Jennifer L. Goralski MD 2 3 Show more Abstract Highly effective modulator therapy (HEMT) has been life-changing for many living with cystic fibrosis (CF), a genetic disease affecting all races and ethnicities.